EverCommerceは,AIツールと強力なリキュアリング収益により,2025年第4四半期に収益とEBITDA予測を上回り,2026年のガイダンスを維持し,3億ドルの株式買い戻しを開始しました. EverCommerce beat revenue and EBITDA forecasts in Q4 2025, driven by AI tools and strong recurring revenue, while maintaining 2026 guidance and launching a $300M share buyback.

EverCommerceは2025年第4四半期に1512億ドルの収益を報告し,前年比5.2%増加し,調整済EBITDAは4420万ドルの予測を上回った. EverCommerce reported Q4 2025 revenue of $151.2 million, a 5.2% year-over-year increase, and adjusted EBITDA of $44.2 million, exceeding guidance. 会社は定期収入と取引量で強大な成果を上げ,Ever Hirst ScribeなどのAI医療機器で高額の顧客の満足感と運用費を表明した. The company achieved strong performance in recurring revenue and transaction volume, with AI-driven healthcare tools like EverHealth Scribe showing high customer satisfaction and operational savings. 株当たり利益のわずかな欠落にもかかわらず,経営陣は6億1,200万ドルから6億3,200万ドルまでの2026年の収益予測を維持し,AI統合と規律的な資本配置に焦点を当て,その中には3億ドルの株式買い戻しプログラムが含まれています. Despite a slight miss on earnings per share, management maintained 2026 revenue guidance between $612 million and $632 million, with a focus on AI integration and disciplined capital allocation, including a $300 million share repurchase program.